| Data demonstrate pharmacokinetic boosting activity of GS 9350. [News]
AIDS Patient Care STDS 2009 Mar; 23(3):220.
Full Citation |
| Bogner JR
[Integrase inhibition] [Journal Article]
MMW Fortschr Med 2009 Apr 30; 151(18):68-71.
Full Citation |
| Lehmann C, Meuer K, Kümmerle T, et al.
[New antiretroviral drug classes in HIV therapy] [Journal Article]
MMW Fortschr Med 2009 Apr 30; 151(18):64-6.
Full Citation |
| Elbasha , Szucs , Chaudhary , et al.
Cost-effectiveness of Raltegravir in Antiretroviral Treatment-Experienced HIV-1-Infected Patients in Switzerland. [Journal Article]
HIV Clin Trials 2009 Jul-Aug; 10(4):233-53.
Abstract | Full Citation |
| Sato M, Kawakami H, Motomura T, et al.
Quinolone carboxylic acids as a novel monoketo acid class of human immunodeficiency virus type 1 integrase inhibitors. [Journal Article]
J Med Chem 2009 Aug 13; 52(15):4869-82.
Abstract | Full Citation |
| FDA notifications. Raltegravir indication extended for treatment-naive patients. [Newspaper Article]
AIDS Alert 2009 Aug; 24(8):93.
Full Citation | Find Related Articles |
| Gray J, Young B
Acute Onset Insomnia Associated with the Initiation of Raltegravir: A Report of Two Cases and Literature Review. [JOURNAL ARTICLE]
AIDS Patient Care STDS 2009 Aug 10.
Full Citation | Publisher Full Text | Find Related Articles |
| Kessl JJ, Eidahl JO, Shkriabai N, et al.
An allosteric mechanism for inhibiting HIV-1 integrase with a small molecule. [JOURNAL ARTICLE]
Mol Pharmacol 2009 Jul 28.
Abstract | Full Citation |
| Wang P, Liu C, Sanches T, et al.
Design and synthesis of novel nitrogen-containing polyhydroxylated aromatics as HIV-1 integrase inhibitors from caffeic acid phenethyl ester. [JOURNAL ARTICLE]
Bioorg Med Chem Lett 2009 Jul 3.
Abstract | Full Citation | Publisher Full Text |
| Xu L, Anderson J, Garrett N, et al.
Dynamics of Raltegravir Resistance Profile in an HIV Type 2-Infected Patient. [JOURNAL ARTICLE]
AIDS Res Hum Retroviruses 2009 Jul 20.
Abstract | Full Citation | Find Related Articles |
  |
